Provided by Tiger Trade Technology Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.0450
+0.00051.12%
Volume:524.68K
Turnover:23.91K
Market Cap:949.62K
PE:0.00
High:0.0480
Open:0.0415
Low:0.0415
Close:0.0445
52wk High:42.00
52wk Low:0.0366
Shares:21.10M
Float Shares:1.76M
Volume Ratio:1.11
T/O Rate:29.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.7052
EPS(LYR):-434.4641
ROE:--
ROA:-210.22%
PB:-0.07
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
CERo Therapeutics Holdings, Inc.
Exchange:
OTCQB
Establishment Date:
2021
Employees:
8
Office Location:
201 Haskins Way,Suite 230,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.